Effect of Portulaca Oleacea L on psychological symptoms of schizophrenic patients

Effect of Portulaca Oleacea L on psychologic symptoms of schizophrenic patients

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201203112085N7

Enrollment

Registered

2012-04-09

Start date

2012-03-11

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

schizophrenia. Residual schizophrenia

Interventions

Intervention 1: Intervention group: 2 months, purslane extract capsule contains 1 gram extract of purslane daily with a routine drug therapy with 4 mg risperidone each 12 hours. Intervention 2: Contr

Treatment - Drugs

Placebo

Intervention group: 2 months, purslane extract capsule contains 1 gram extract of purslane daily with a routine drug therapy with 4 mg risperidone each 12 hours.

Control group: routine treatment with 4 mg risperidone two times daily in addition to placebo capsule ( startch) daily for two months.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: diagnosis of schizophrenia, admission in Sina hospital Exclusion criteria: Having allergy to Portulaca Oleacea L, Gastrointestinal problem(GI problem)

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Positive and negative symptoms and CRP and MDA serum level of patients. Timepoint: at base line, two months later. Method of measurement: positive and negative symptom questionnaire and Blood test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNeda Parvin

Shahrekord Medical university of sciences.

np285@yahoo.com+98 38 1333 5648

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026